Is Pharmaids Pharmaceuticals a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Pharmaids Pharmaceuticals Ltd is a below average quality company .

Is Pharmaids Pharmaceuticals undervalued or overvalued?

The key valuation ratios of Pharmaids Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Pharmaids Pharmaceuticals share price return in the past 10 years?

Pharmaids Pharmaceuticals Ltd share price has appreciated 38.2% annually (CAGR) over the past ten years.

Is Pharmaids Pharmaceuticals a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Pharmaids Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the P/E ratio of Pharmaids Pharmaceuticals?

The latest standalone P/E ratio of Pharmaids Pharmaceuticals as of 18-Apr-2024 is 0.00.

What is the P/B ratio of Pharmaids Pharmaceuticals?

The latest standalone P/B ratio of Pharmaids Pharmaceuticals as of 18-Apr-2024 is 3.22.

What is the 52-week high and low of Pharmaids Pharmaceuticals?

The 52-week high of Pharmaids Pharmaceuticals is Rs. 79.23 and the 52-week low is Rs. 20.10.

Pharmaids Pharmaceuticals Ltd - Stock Valuation and Financial Performance

Name: Pharmaids Pharmaceuticals
Brand: Pharmaids Pharmaceuticals

BSE: 524572 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Pharmaids Pharma Share Price

₹66.10 3.14 4.99%
as on 18-Apr'24 16:01

10 Year X-Ray of Pharmaids Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	-14.6%	-3.1%	-19.8%	-14%	-31.2%	-3.8%	0.4%	1.1%	1.7%	-48.6%	-
Value Creation Index ⓘ	-2.0	-1.2	-2.4	-2.0	-3.2	-1.3	-1.0	-0.9	-0.9	-4.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	1.4	1.7	1.7	1.2	0.5	0.6	0	8.6	3.9	0	0
Sales YoY Gr.	-	22.7%	-2.9%	-28.6%	-62.5%	24.4%	-100%	NA	-53.9%	-100%	-
Adj EPS ⓘ	-1	-0.2	-1.2	-0.8	-1.1	-0.2	0	0.1	0.1	-3.5	-2.7
YoY Gr.	-	NA	NA	NA	NA	NA	NA	200%	55.6%	-2614.3%	-
BVPS (₹) ⓘ	5.4	5.1	3.9	4.3	3.1	8.2	8.2	8.3	8.4	10.2	20.5
Adj Net Profit ⓘ	-0.4	-0.1	-0.4	-0.3	-0.4	-0.2	0	0.1	0.2	-7.6	-10
Cash Flow from Ops. ⓘ	0.1	0.2	0	0.3	-0.2	-0.1	-0.8	0.4	-0.3	-4	-
Debt/CF from Ops. ⓘ	4.4	1.4	28.6	0	0	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-100%	-100%	NA	-100%
Adj EPS ⓘ	NA	NA	-589.6%	-2614.3%
BVPSⓘ	7.4%	27%	7.6%	21.3%
Share Price	38.2%	69.6%	64.2%	190.2%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	-17.8	-3.7	-26.2	-18.5	-31.2	-3.8	0.4	1.1	1.7	-48.6	-17.7
Op. Profit Mgn % ⓘ	-31.1	-5.3	-20.5	-28.6	-86	-18.1	0	1.3	3.5	0	-6166.7
Net Profit Mgn % ⓘ	-25.2	-3.8	-23.6	-21.1	-85.9	-31.6	0	1.1	3.7	0	-48143.6
Debt to Equity ⓘ	0.2	0.2	0.4	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	584	424	385	470	1,003	2,955	0	334	831	0	0
Cash Conv. Cycle ⓘ	322	205	209	214	359	345	0	3	12	0	0

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at -25.00%

Latest Financials - Pharmaids Pharmaceuticals Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-2.7	-2.7
TTM Sales (₹ Cr.)	0	0
BVPS (₹.) ⓘ	20.5	20.6
Reserves (₹ Cr.) ⓘ	37	37
P/BV ⓘ	3.22	3.22
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	20.10 / 79.23
All Time Low / High (₹)	1.00 / 79.23
Market Cap (₹ Cr.)	233
Equity (₹ Cr.)	35.3
Face Value (₹)	10
Industry PE ⓘ	47.6

Management X-Ray of Pharmaids Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Pharmaids Pharma

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Pharmaids Pharma

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	1	2	2	1	0	1	0	9	4	0
Operating Expenses ⓘ	2	2	2	2	1	1	0	8	4	10
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	1	1	1	1	0	0	0	8	4	1
Employee Cost	0	0	0	0	0	0	0	0	0	1
Other Costs ⓘ	1	1	1	1	0	0	0	0	0	8
Operating Profit ⓘ	0	0	0	0	0	0	0	0	0	-10
Operating Profit Margin (%)	-31.0%	-5.3%	-20.5%	-28.6%	-86.0%	-18.1%	-	1.3%	3.5%	-
Other Income ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0	0
Depreciation ⓘ	0	0	0	0	0	0	0	0	0	0
Exceptional Items ⓘ	0	0	0	1	0	0	0	0	0	0
Profit Before Tax ⓘ	0	0	0	0	0	0	0	0	0	-10
Tax ⓘ	0	0	0	0	0	0	0	0	0	-2
Profit After Tax	0	0	0	0	0	0	0	0	0	-8
PAT Margin (%)	-25.2%	-3.8%	-23.6%	9.1%	-85.9%	-31.6%	-	1.1%	3.7%	-
Adjusted EPS (₹)	-1.1	-0.2	-1.2	0.3	-1.2	-0.2	0.0	0.1	0.1	-3.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	2	2	1	1	1	8	8	9	9	22
Share Capital ⓘ	3	3	3	3	3	10	10	10	10	21
Reserves ⓘ	-2	-2	-2	-2	-2	-2	-2	-2	-2	1
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	0	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Trade Payables	1	0	0	0	0	0	0	1	2	2
Others Liabilities ⓘ	0	0	0	0	0	0	0	0	0	-2
Total Liabilities ⓘ	3	3	2	2	1	9	8	9	11	22
Fixed Assets
Gross Block	2	2	2	0	0	0	1	1	1	0
Accumulated Depreciation	1	2	2	0	0	0	0	0	0	0
Net Fixed Assetsⓘ	1	0	0	0	0	0	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0	0	0	2
Investmentsⓘ	0	0	0	0	0	0	0	0	0	3
Inventories	0	0	0	0	0	0	0	0	1	0
Trade Receivables	1	1	1	1	1	1	0	0	1	1
Cash Equivalents ⓘ	0	0	0	1	0	0	0	0	0	13
Others Assetsⓘ	1	0	0	0	1	7	8	7	8	2
Total Assets ⓘ	3	3	2	2	1	9	8	9	11	22

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'20	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	-1	0	-4
PBT ⓘ	0	0	-10
Adjustment ⓘ	0	0	0
Changes in Working Capital ⓘ	-0	-0	6
Tax Paid ⓘ	0	0	0
Cash Flow From Investing Activity ⓘ	1	0	-5
Capex	0	0	-2
Net Investments	0	0	-3
Others ⓘ	1	0	0
Cash Flow From Financing Activityⓘ	0	0	21
Net Proceeds from Shares ⓘ	0	0	21
Net Proceeds from Borrowing ⓘ	0	0	0
Interest Paid ⓘ	0	0	0
Dividend Paid ⓘ	0	0	0
Others ⓘ	0	0	0
Net Cash Flow ⓘ	0	0	12

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	-17.79	-3.71	-26.21	7.99	-31.24	-3.76	0.4	1.1	1.69	-49.34
ROCE (%)	-14.96	-4.99	-21.19	7.61	-29.73	-3.02	-4.45	1.04	1.66	-63.94
Asset Turnover Ratio	0.46	0.64	0.7	0.56	0.27	0.11	0	1.01	0.4	0
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	368	250	237	283	530	457	0	12	75	0
Inventory Days	66	60	63	81	0	0	0	16	58	0
Payable Days	168	165	135	242	234	176	0	11	143	861

Pharmaids Pharmaceuticals Ltd Stock News

Pharmaids Pharmaceuticals Ltd FAQs

What is the share price of Pharmaids Pharma?

Company share prices are keep on changing according to the market conditions. The closing price of Pharmaids Pharma on 18-Apr-2024 16:01 is ₹66.10.

What is the market cap of Pharmaids Pharma?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 18-Apr-2024 16:01 the market cap of Pharmaids Pharma stood at ₹233.1.

What is the P/E ratio of Pharmaids Pharma?

The latest P/E ratio of Pharmaids Pharma as of 18-Apr-2024 16:01 is 0.00.

What is the P/B ratio of Pharmaids Pharma?

The latest P/B ratio of Pharmaids Pharma as of 18-Apr-2024 16:01 is 3.22.

What is the 52-week high and low of Pharmaids Pharma?

The 52-week high of Pharmaids Pharma is ₹79.23 and the 52-week low is ₹20.10.

What is the TTM revenue of Pharmaids Pharma?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Pharmaids Pharma is ₹0.02 ( Cr.) .

About Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals Limited Incorporated in the year 1989 at Hyderabad (Telangana, India). The company is suppliers of Quality Grade range of Specialty chemicals, Skin care, Hospital care and Generic products in the areas of Orthopedic, Neuro and Gastro etc. Its technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygienic standards. Its professionals strive to offer best quality and high purity to attain maximum client's satisfaction. The company’s offered product range is highly acknowledged in the market for its precise composition long shelf life, hygienic processing techniques, premium quality and high purity.

Business area of the company

The Company is engaged in the business of Trading and Manufacturing of Generics, Bulk Drugs and Intermediaries, etc.

Products